skip to content

Laferriere, Joseph Raymond Gilles Arthur

CPSO#: 33396

MEMBER STATUS
Active Member as of 22 Jun 1982
CURRENT OR PAST CPSO REGISTRATION CLASS
Restricted as of 27 Nov 1995

Summary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur aliquet quam id dui posuere blandit. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Donec sollicitudin molestie malesuada. Pellentesque in ipsum id orci porta dapibus.

Former Name: No Former Name

Gender: Male

Languages Spoken: English, French

Education: McGill University Faculty of Medicine an, 1976

Practice Information

Primary Location of Practice
Pitt Street Medical Centre
1335 Pitt Street
Cornwall ON  K6J 3T7
Phone: (613) 932-6163
Fax: (613) 932-5484 Electoral District: 07

Additional Practice Location(s)

Cornwall Health Care Centre Walk In
Suite 128
820 McConnell Avenue
Cornwall ON  K6H 4M4
Canada
Phone: (613) 936-1564
Fax: (613) 936-0174
County: County of Stormont, Dundas and Glengarry
Electoral District: 07

Medical Licences in Other Jurisdictions

Effective September 1, 2015, the College by-laws require the College to indicate on the register if the member has a licence or is registered to practise medicine in a jurisdiction outside Ontario, if this is known to the College.



Quebec

Hospital Privileges

No Privileges reported.


Hospital Notices

Source:  Hospital
Active Date:  September 5, 2018
Expiry Date:  
Summary:  
On September 5, 2018, Cornwall Community Hospital (CCH) notified the College, pursuant to s. 33(d) of the Public Hospitals Act and s.85.5(2) of the Health Professions Procedural Code, Regulated Health Professions Act, that Dr. Joseph Raymond Gilles Laferriere took a voluntary leave of absence from his duties during the course of an investigation by CCH into Dr. Laferriere's practice.

Specialties

Specialty Issued On Type
No Speciality Reported

Registration History

Action Issue Date
First certificate of registration issued: Independent Practice Certificate Effective: 22 Jun 1982
Transfer of class of certificate to: Restricted certificate Effective: 27 Nov 1995
Terms and conditions imposed on certificate by Executive Committee Effective: 27 Nov 1995
Terms and conditions amended by member Effective: 07 Sep 2007
Terms and conditions amended by member Effective: 22 Jan 2010
Terms and conditions amended by member Effective: 30 Sep 2019
Terms and conditions amended by member Effective: 02 May 2022
Terms and conditions amended by member Effective: 01 Feb 2023

Practice Restrictions

Imposed By Effective Date Expiry Date Status
member Effective: 01 Feb 2023 Active
 1 of 2 

As from February 1st, 2023, the following are imposed as terms, conditions and limitations on the certificate of registration held by Dr. Laferriere in accordance with an undertaking and consent given by Dr. Laferriere to the College of Physicians and Surgeons of Ontario:

UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT
("Undertaking")

of

DR. JOSEPH RAYMOND GILLES ARTHUR LAFERRIERE
("Dr. Laferriere")

to

COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
(the "College")
________________________________________

A.	PREAMBLE

(1)	In this Undertaking:

"Code" means the Health Professions Procedural Code, which is Schedule 2 to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as amended; 
"Discipline Tribunal" means the Ontario Physicians and Surgeons Discipline Tribunal of the College;
"OHIP" means the Ontario Health Insurance Plan;
"Ontario Physicians and Surgeons Discipline Tribunal" means the Discipline Committee established under the Code;

"Public Register" means the College's register that is available to the public.

(2)	I, Dr. Laferriere, certificate of registration number 33396, am a member of the College.
  
(3)	I, Dr. Laferriere, acknowledge that the College conducted an investigation bearing File Number CAS-367541-X6G7P8 (the "Investigation") into my general medicine practice.

B.	UNDERTAKING

(4)	I, Dr. Laferriere, undertake to abide by the provisions of this Undertaking, effective immediately. 

(5)	Practice Restrictions

(a)	I, Dr. Laferriere, undertake to restrict my practice as follows:

(i)	I will not provide medical exemptions in relation to vaccines for COVID-19;

(ii)	I will not provide medical exemptions in relation to mask requirements for COVID-19;

(iii)	I will not provide medical exemptions in relation to diagnostic testing for COVID-19;

(iv)	I will not prescribe colchicine or hydroxychloroquine in relation to COVID-19; and

(v)	I will not prescribe ivermectin. 

(6)	Posting a Sign

(a)	I, Dr. Laferriere, undertake that I shall post a sign in all waiting rooms, examination rooms and consulting rooms, in all my Practice Locations, in a clearly visible and secure location, at all times whether or not I am physically present at the Practice Location, in the form set out at Appendix "A."  If providing care in a virtual setting, I shall display the sign to the patient at the outset of the patient encounter. For further clarity, this sign shall state as follows: "Dr. Laferriere must not provide medical exemptions in relation to vaccines, mask requirements or diagnostic testing for COVID-19. Dr. Laferriere must not prescribe colchicine or hydroxychloroquine in relation to COVID-19. Dr. Laferriere must not prescribe ivermectin. Further information may be found on the College of Physicians and Surgeons of Ontario website at www.cpso.on.ca".

(b)	I, Dr. Laferriere, undertake to post a certified translation in any language in which I provide services, of the sign described in section (6)(a) in all waiting rooms of all my Practice Locations, in a clearly visible and secure location, in the form set out at Appendix "A." 

(c)	I, Dr. Laferriere, undertake to provide the certified translation described in section (6)(b), to the College within thirty (30) days of executing this Undertaking.

(d)	I, Dr. Laferriere, undertake that if I elect, after the execution of this Undertaking, to provide services in any other language, I will notify the College prior to providing any such services. 

(e)	I, Dr. Laferriere, undertake to provide to the College the certified translation described in section (6)(b) prior to beginning to provide services in any language described in section (6)(d).

(7)	Monitoring 

(a)	I, Dr. Laferriere, undertake to inform the College of each and every location at which I practice, delegate, or have privileges, including, but not limited to, any hospitals, clinics, offices, and any Out-of-Hospital Premises and Independent Health Facilities with which I am affiliated, in any jurisdiction (collectively my "Practice Location" or "Practice Locations"), within five (5) days of executing this Undertaking.  Going forward, I further undertake to inform the College of any and all new Practice Locations within five (5) days of commencing practice at that location.

(b)	I, Dr. Laferriere, give my irrevocable consent to the College to make appropriate enquiries of OHIP, and/or any person who or institution that may have relevant information, in order for the College to monitor my compliance with the provisions of this Undertaking.

(c)	I, Dr. Laferriere, acknowledge that I have executed the OHIP consent form, attached hereto as Appendix "B". 

(d)	I, Dr. Laferriere, undertake that I will submit to, and not interfere with, unannounced inspections of my Practice Locations and patient charts by a College representative for the purposes of monitoring my compliance with the provisions of this Undertaking.

C.	ACKNOWLEDGEMENT

(8)	I, Dr. Laferriere, acknowledge that all appendices attached to or referred to in this Undertaking form part of this Undertaking.

(9)	I, Dr. Laferriere, acknowledge and undertake that I shall be solely responsible for payment of all fees, costs, charges, expenses, etc. arising from the implementation of any of the provisions of this Undertaking. 

(10)	I, Dr. Laferriere, acknowledge that I have read and understand the provisions of this Undertaking and that I have obtained independent legal counsel in reviewing and executing this Undertaking, or have waived my right to do so.

(11)	I, Dr. Laferriere, acknowledge that the College will provide this Undertaking to any Chief of Staff, or a colleague with similar responsibilities, at any Practice Location ("Chief of Staff" or "Chiefs of Staff").

(12)	I, Dr. Laferriere, acknowledge that a breach by me of any provision of this Undertaking may constitute an act of professional misconduct and/or incompetence, and may result in a referral of specified allegations to the Discipline Tribunal.

(13)	I, Dr. Laferriere, acknowledge that this Undertaking constitutes terms, conditions, and limitations on my certificate of registration for the purposes of section 23 of the Code. 


(14)	Public Register
(a)	I, Dr. Laferriere, acknowledge that, during the time period that this Undertaking remains in effect, this Undertaking shall be posted on the Public Register.

(b)	I, Dr. Laferriere, acknowledge that, in addition to this Undertaking being posted in accordance with section (14)(a) above, the following summary shall be posted on the Public Register during the time period that this Undertaking remains in effect:

A College investigation was conducted into Dr. Laferriere's general medicine practice.  As a result of the investigation: 

Dr. Laferriere will not provide medical exemptions in relation to vaccines for COVID-19;

Dr. Laferriere will not provide medical exemptions in relation to mask requirements for COVID-19;

Dr. Laferriere will not provide medical exemptions in relation to diagnostic testing for COVID-19;

Dr. Laferriere will not prescribe colchicine or hydroxychloroquine in relation to COVID-19; and

Dr. Laferriere will not prescribe ivermectin. 

D.	CONSENT

(15)	I, Dr. Laferriere, give my irrevocable consent to the College to provide all Chiefs of Staff with any information the College has that led to the circumstances of my entering into this Undertaking and/or any information arising from the monitoring of my compliance with this Undertaking.

2 of 2

As from September 30, 2019, the following is imposed as terms, conditions and
            limitations on the certificate of registration held by Dr. Joseph Raymond
            Gilles Arthur Laferriere in accordance with an undertaking and consent given by
            Dr. Laferriere to the College of Physicians and Surgeons of Ontario:

                        UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT 
                                          ("Undertaking")
                  
                                                of
                  
                        DR. JOSEPH RAYMOND GILLES ARTHUR LAFERRIERE
                                          ("Dr. Laferriere")
                  
                                                to
                  
                        COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
                                          (the "College")
                  
                  
                  
            A.    PREAMBLE

            (1)   In this Undertaking:

                  "Code" means the Health Professions Procedural Code, which is Schedule 2
                  to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as
                  amended; 
                  
                  "ICR Committee" means the Inquiries, Complaints and Reports Committee of
                  the College.
                  
                  "Narcotic Drugs" means from the Narcotic Control Regulations made under
                  the Controlled Drugs and Substances Act, S.C., 1996, c. 19, as amended.
                  
                  "Narcotic Preparations" means from the Narcotic Control Regulations made
                  under the Controlled Drugs and Substances Act, S.C., 1996, c. 19, as
                  amended.
                  
                  "Controlled Drugs" means from Part G of the Food and Drug Regulations
                  under the Food and Drugs Act, S.C., 1985, c. F-27, as amended.
                  
                  "Benzodiazepines and Other Targeted Substances" means from the
                  Benzodiazepines and Other Targeted Substances Regulations made under the
                  Controlled Drugs and Substances Act., S.C., 1996, c. 19, as amended 
                  
                  (A summary of the above-named drugs [from Appendix I to the Compendium of
                  Pharmaceuticals and Specialties] is attached hereto as Schedule "A"; and
                  links to the current regulatory lists are attached hereto as Schedule
                  "B")
                  
                  "Monitored Drugs" means as defined under the Narcotics Safety and
                  Awareness Act, 2010, S.O. 2010, c. 22, as amended, with a link to the
                  current regulatory list attached hereto at Schedule "C".
                  
                  "NMS" means the Drug Program Services Branch, the Narcotics Monitoring
                  System implemented under the Narcotics Safety and Awareness Act, 2010,
                  S.O. 2010, c. 22, as amended;
                  
                  "OHIP" means the Ontario Health Insurance Plan;
                  
                  "Public Register" means the College's register that is available to the
                  public.
                  
            (2)   I, Dr. Laferriere, certificate of registration number 33396, am a member
                  of the College.  

            (3)   I, Dr. Laferriere, acknowledge that I entered into an Undertaking with
                  the College on November 27, 1995 (the "1995 Undertaking").  Once signed,
                  this Undertaking replaces the 1995 Undertaking and the 1995 Undertaking
                  is no longer in effect.

            B.    UNDERTAKING

            (4)   I, Dr. Laferriere, undertake to abide by the provisions of this
                  Undertaking effective immediately (the "Effective Date").

            Practice Restrictions

            (5)   I, Dr. Laferriere, undertake that I will not issue new prescriptions or
                  renew existing prescriptions for or administer Narcotic Drugs, Narcotic
                  Preparations, Controlled Drugs, Benzodiazepines and Other Targeted
                  Substances, or Monitored Drugs, subject to the following exceptions:

                  (a)   I, Dr. Laferriere, may prescribe Narcotic Drugs, Narcotic
                        Preparations, Controlled Drugs, Benzodiazepines and Other Targeted
                        Substances, or Monitored Drugs to patients residing in a
                        rehabilitation or long-term care facility; and
                  
                  (b)   I, Dr. Laferriere, may prescribe up to a one month supply of
                        Narcotic Drugs, Narcotic Preparations, Controlled Drugs,
                        Benzodiazepines and Other Targeted Substances, or Monitored Drugs
                        to patients being released from a rehabilitation or long-term care
                        facility.
                  
            (6)   Until such time as the Reassessment set out at section 10 of this
                  Undertaking is deemed to be completed by the College, I, Dr. Laferriere,
                  shall keep a Log of all prescriptions for Narcotic Drugs, Narcotic
                  Preparations, Controlled Drugs, Benzodiazepines and Other Targeted
                  Substances and Monitored Drugs, in the form attached as set out in
                  Schedule "D", which will include at least the following information (the
                  "Prescribing Log"):  

                        (i)   the date of the appointment;
                  
                        (ii)  the name of the patient and chart/file number;
                  
                        (iii) the name of the medication prescribed, dose, direction,
                              number of tablets to be dispensed and frequency;
                  
                        (iv)  the clinical indication;
                  
                        (v)   whether the prescription is for a new medication and/or
                              different dose or frequency than currently prescribed to the
                              patient (Y/N); 
                  
                        (vi)  Dr. Laferriere's signature;
                  
                        (vii) the date of the Clinical Supervisor's review (if applicable,
                              as set out below); and
                  
                        (viii)the Clinical Supervisor's signature (if applicable, as set
                              out below).
                  
            (7)   I, Dr. Laferriere, undertake to keep a copy of all prescriptions I write
                  for Narcotic Drugs, Narcotic Preparations, Controlled Drugs,
                  Benzodiazepines and Other Targeted Substances and Monitored Drugs, in the
                  corresponding patient chart.

            (8)   Clinical Supervision

                  (a)   I, Dr. Laferriere, undertake to practise under the guidance of a
                        clinical supervisor or clinical supervisors acceptable to the
                        College (the "Clinical Supervisor" or "Clinical Supervisors"), for
                        three (3) months ("Clinical Supervision"). 
                  
                  (b)   I, Dr. Laferriere, acknowledge that I have reviewed the Clinical
                        Supervisor's undertaking, attached hereto as Schedule "E", and
                        understand what is required of the Clinical Supervisor. The
                        Clinical Supervisor will, at minimum:
                  
                        i.    Facilitate the education program set out in the
                              Individualized Education Plan ("IEP"), attached hereto as
                              Schedule "F";
                  
                        ii.   Review the materials provided by the College and have an
                              initial meeting to discuss the objectives for the Clinical
                              Supervision and  practice improvement recommendations;
                  
                        iii.  Meet with me at my Practice Location, or another location
                              approved by the College, once every month;
                  
                        iv.   Review at least fifteen (15) of my patient charts at every
                              meeting to whom I have prescribed Narcotic Drugs, Narcotic
                              Preparations, Controlled Drugs, Benzodiazepines and Other
                              Targeted Substances and Monitored Drugs since the Clinical
                              Supervisor(s)'s prior review, or if since the Clinical
                              Supervisor(s)'s prior review there are not 15 patients listed
                              in the Prescribing Log to whom I have prescribed Narcotic
                              Drugs, Narcotic Preparations, Controlled Drugs,
                              Benzodiazepines and Other Targeted Substances and Monitored
                              Drugs, then the charts of all patients listed in the
                              Prescribing Log since the Clinical Supervisor's prior review;
                  
                        v.    Sign and date the Prescribing Log to confirm the charts that
                              the Clinical Supervisor(s) has reviewed and discussed with
                              me;
                  
                        vi.   Discuss any concerns arising from the chart reviews;
                  
                        vii.  Make recommendations to me for practice improvements and
                              ongoing professional development and inquire into my
                              compliance with the recommendations; 
                  
                        viii. Perform any other duties, such as reviewing other documents
                              or conducting interviews with staff or colleagues, that the
                              Clinical Supervisor deems necessary to my Clinical
                              Supervision; and
                  
                        ix.   Submit one written report to the College upon completion of
                              the Clinical Supervision, or more frequently if the Clinical
                              Supervisor has concerns about my standard of practice.
                  
                  (c)   I, Dr. Laferriere, acknowledge that the charts reviewed shall be
                        selected by the Clinical Supervisor based on the educational needs
                        identified in the IEP and concerns that may arise during the period
                        of Clinical Supervision.
                  
                  (d)   I, Dr. Laferriere, undertake to cooperate fully with the Clinical
                        Supervision of my practice, conducted under the terms of this
                        Undertaking and Schedule "E" attached, and to abide by the
                        reasonable recommendations of my Clinical Supervisor(s), including
                        but not limited to, any recommended practice improvements and
                        ongoing professional development.
                  
                  (e)   I, Dr. Laferriere, undertake to ensure that Schedule "E" to this
                        Undertaking, is signed and delivered to the College within thirty
                        (30) days of the Effective Date.
                  
                  (f)   I, Dr. Laferriere, undertake that if a person who has given an
                        undertaking in Schedule "E" to this Undertaking is unable or
                        unwilling to continue to fulfill its provisions, I shall, within
                        twenty (20) days of receiving notice of same, obtain an executed
                        undertaking in the same form from a similarly qualified person who
                        is acceptable to the College and ensure that it is delivered to the
                        College within that time.
                  
                  (g)   I, Dr. Laferriere, undertake that if I am unable to obtain a
                        Clinical Supervisor on the provisions set out under sections (e)
                        and/or (f) above, I will cease prescribing Narcotic Drugs, Narcotic
                        Preparations, Controlled Drugs, Benzodiazepines and Other Targeted
                        Substances and Monitored Drugs until such time as I have obtained a
                        Clinical Supervisor acceptable to the College.  
                  
                  (h)   I, Dr. Laferriere, acknowledge that if I am required to cease
                        prescribing Narcotic Drugs, Narcotic Preparations, Controlled
                        Drugs, Benzodiazepines and Other Targeted Substances and Monitored
                        Drugs as a result of section (g) above this will constitute a term,
                        condition or limitation on my certificate of registration and that
                        term, condition or limitation will be included on the public
                        register.
                  
            (9)   Professional Education  

                  (a)   I, Dr. Laferriere, undertake to participate in and successfully
                        complete all elements of the detailed IEP, attached hereto as
                        Schedule "F", including but not limited to, the following elements
                        of professional education (the "Professional Education"):
                  
                        (i)   University of Toronto Faculty of Medicine program in Safer
                              Opioid Prescribing (all three webinars and in-person
                              workshop): www.cepd.utoronto.ca/opioidprescribing;
                  
                        (ii)  Review and discuss with my Clinical Supervisor(s) the
                              following resources:
                  
                              1.    CPSO Policy "Prescribing Drugs":
                                    http://www.cpso.on.ca/Policies-Publications/Policy/Prescribing-Drugs;
                                    and
                  
                              2.    2017 Canadian Guideline for Opioids for Chronic
                                    Non-Cancer Pain:
                                    http://nationalpaincentre.mcmaster.ca/guidelines.html;
                                    and
                  
                        (iii) any additional professional education recommended by my
                              Clinical Supervisor(s).
                  
                  (b)   I, Dr. Laferriere, undertake to provide proof to the College of my
                        successful completion of each element of the Professional Education
                        specified above, including proof of registration, attendance and
                        participant assessment reports where available, within one (1)
                        month of completion of each element. I acknowledge that the College
                        will determine, in its sole discretion, whether I have successfully
                        completed each element of the Professional Education.
                  
                  (c)   I, Dr. Laferriere, undertake to complete the Professional Education
                        within three (3) months of the Effective Date or, if no
                        satisfactory program is available by that time, by the first
                        possible opportunity thereafter.
                  
                  (d)   I, Dr. Laferriere, acknowledge that a report or reports may be
                        provided to the College regarding my progress and compliance with
                        the Professional Education.
                  
            (10)  Reassessment of Practice

                  (a)   I, Dr. Laferriere, undertake that, approximately three (3) months
                        after the completion of the Clinical Supervision set out in section
                        8 above, I will submit to a reassessment of my prescribing of
                        Narcotic Drugs, Narcotic Preparations, Controlled Drugs,
                        Benzodiazepines and other targeted substances, or Monitored Drugs
                        ("the Reassessment") by an assessor or assessors selected by the
                        College (the "Assessor" or "Assessors").  I acknowledge that the
                        Reassessment may include a chart review, direct observation of my
                        care, interviews with colleagues and co-workers, feedback from
                        patients and any other tools deemed necessary by the College.
                  
                  (b)   I, Dr. Laferriere, undertake to co-operate fully with the
                        Reassessment, conducted under the term of this Undertaking. 
                  
                  (c)   I, Dr. Laferriere, acknowledge that my Clinical Supervisor may
                        receive and review the findings of the Assessor, and may discuss
                        with the Assessor any issues or concerns arising from the
                        Reassessment.
                  
                  (d)   I, Dr. Laferriere, acknowledge that the results of the Reassessment
                        will be provided to me and reported to the College and the
                        Reassessment may form the basis of further action by the College. 
                  
            (11)  Monitoring 

                  (a)   I, Dr. Laferriere, undertake to inform the College of each and
                        every location at which I practise or have privileges, including,
                        but not limited to, any hospitals, clinics, offices, and any
                        Independent Health Facilities with which I am affiliated, in any
                        jurisdiction (collectively my "Practice Location" or "Practice
                        Locations"), within five (5) days of executing this Undertaking.
                        Going forward, I further undertake to inform the College of any and
                        all new Practice Locations within five (5) days of commencing
                        practice at that location.
                  
                  (b)   I, Dr. Laferriere, undertake that I will submit to, and not
                        interfere with, unannounced inspections of my Practice Locations
                        and patient records by a College representative for the purposes of
                        monitoring my compliance with the provisions of this Undertaking.
                  
                  (c)   I, Dr. Laferriere, give my irrevocable consent to the College to
                        make appropriate enquiries of OHIP, NMS and/or any person who or
                        institution that may have relevant information, in order for the
                        College to monitor my compliance with the provisions of this
                        Undertaking.
                  
                  (d)   I, Dr. Laferriere, acknowledge that I have executed the OHIP and
                        NMS consent form(s), attached hereto as Schedule "G" and Schedule
                        "H", respectively. 
                  
            C.    ACKNOWLEDGEMENT

            (12)  I, Dr. Laferriere, acknowledge that all schedules attached to or referred
                  to in this Undertaking form part of this Undertaking.

            (13)  I, Dr. Laferriere, acknowledge that I shall be solely responsible for
                  payment of all fees, costs, charges, expenses, etc. arising from the
                  implementation of any of the provisions of this Undertaking. 

            (14)  I, Dr. Laferriere, acknowledge and confirm that I have read and
                  understand the provisions of this Undertaking and that I have obtained
                  independent legal counsel in reviewing and executing this Undertaking, or
                  have waived my right to do so.

            (15)  I, Dr. Laferriere, acknowledge that the College will provide this
                  Undertaking to any Chief of Staff, or a colleague with similar
                  responsibilities, at any Practice Location ("Chief(s) of Staff").

            (16)  I, Dr. Laferriere, acknowledge that a breach by me of any provision of
                  this Undertaking may constitute an act of professional misconduct and/or
                  incompetence, and may result in a referral of specified allegations to
                  the Discipline Committee of the College.

            (17)  I, Dr. Laferriere, acknowledge that this entire Undertaking constitutes
                  terms, conditions, and limitations on my certificate of registration for
                  the purposes of section 23 of the Code. 

            (18)  Public Register

                  (a)   I, Dr. Laferriere, acknowledge that, during the time period that
                        this Undertaking remains in effect, this Undertaking shall be
                        posted on the Public Register.
                  
                  (b)   I, Dr. Laferriere, acknowledge that, in addition to this
                        Undertaking being posted in accordance with section (a) above, the
                        following summary shall be posted on the Public Register during the
                        time period that this Undertaking remains in effect:
                  
                              Dr. Laferriere must not issue new prescriptions or renew
                              existing prescriptions for or administer Narcotic Drugs,
                              Narcotic Preparations, Controlled Drugs, Benzodiazepines and
                              Other Targeted Substances, or Monitored Drugs, subject to the
                              following exceptions:
                  
                                    Dr. Laferriere may prescribe Narcotic Drugs, Narcotic
                                    Preparations, Controlled Drugs, Benzodiazepines and
                                    Other Targeted Substances, or Monitored Drugs to
                                    patients residing in a rehabilitation or long-term care
                                    facility; and
                  
                                    Dr. Laferriere may prescribe up to a one month supply
                                    of Narcotic Drugs, Narcotic Preparations, Controlled
                                    Drugs, Benzodiazepines and Other Targeted Substances,
                                    or Monitored Drugs to patients being released from a
                                    rehabilitation or long-term care facility.
                  
            D.    CONSENT

            (19)  I, Dr. Laferriere, give my irrevocable consent to the College to provide
                  the following information to any person who requires this information for
                  the purposes of facilitating my completion of the Professional Education
                  and to all Clinical Supervisors, and/or Assessors:

                  (a)   any information the College has that led to the circumstances of my
                        entering into this Undertaking;
                  
                  (b)   any information arising from any investigation into, or assessment
                        of, my practice; and 
                  
                  (c)   any information arising from the monitoring of my compliance with
                        this Undertaking.
                  
            (20)  I, Dr. Laferriere, give my irrevocable consent to the College to provide
                  all Chiefs of Staff with any information the College has that led to the
                  circumstances of my entering into this Undertaking and/or any information
                  arising from the monitoring of my compliance with this Undertaking.

            (21)  I, Dr. Laferriere, give my irrevocable consent to any person who
                  facilitates my completion of the Professional Education, and to all
                  Clinical Supervisors, Chiefs of Staff and Assessors, to disclose to the
                  College, and to one another, any information:

                  (a)   relevant to this Undertaking;
                  
                  (b)   relevant to the provisions of the Clinical Supervisor's undertaking
                        set out at Schedule "E";
                  
                  (c)   relevant to the Reassessment;
                  
                  (d)   relevant for the purposes of monitoring my compliance with this
                        Undertaking; and/or 
                  
                  (e)   which comes to his or her attention in the course of providing the
                        Professional Education and which he or she reasonably believes
                        indicates a potential risk of harm to my patients.

Concerns

Source: Member
Active Date: February 1, 2023
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Laferriere to the College of Physicians and Surgeons of Ontario, effective February 1st, 2023:
 
A College investigation was conducted into Dr. Laferriere’s general medicine practice.  As a result of the investigation:
Dr. Laferriere will not provide medical exemptions in relation to vaccines for COVID-19;
Dr. Laferriere will not provide medical exemptions in relation to mask requirements for COVID-19;
Dr. Laferriere will not provide medical exemptions in relation to diagnostic testing for COVID-19;
Dr. Laferriere will not prescribe colchicine or hydroxychloroquine in relation to COVID-19; and
Dr. Laferriere will not prescribe ivermectin.

 

Source: Member
Active Date: September 30, 2019
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Joseph Raymond Gilles Arthur Laferriere to the College of Physicians and Surgeons of Ontario, effective September 30, 2019:

Dr. Laferriere must not issue new prescriptions or renew existing prescriptions for or administer Narcotic Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other Targeted Substances, or Monitored Drugs, subject to the following exceptions:

Dr. Laferriere may prescribe Narcotic Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other Targeted Substances, or Monitored Drugs to patients residing in a rehabilitation or long-term care facility; and

Dr. Laferriere may prescribe up to a one month supply of Narcotic Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other Targeted Substances, or Monitored Drugs to patients being released from a rehabilitation or long-term care facility.

CPSO will be closed on March 29, 2024. We will re-open on Monday, April 1, 2024, at 8:00 am.